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The progesterone receptor (PGR) is a nuclear receptor transcription factor that is essential for female fertility,
in part due to its control of oocyte release from the ovary, or ovulation. In all mammals studied to date, ovarian
expression of PGR is restricted primarily to granulosa cells of follicles destined to ovulate. Granulosa cell
expression of PGR is induced by the pituitary Luteinizing Hormone (LH) surge via mechanisms that are not
entirely understood, but which involve activation of Protein Kinase A and modification of Sp1/Sp3 transcription
factors on the PGR promoter. Null mutations for PGR or treatment with PGR antagonists block ovulation in
all species analyzed, including humans.The cellular mechanisms by which PGR regulates ovulation are
currently under investigation, with several downstream pathways having been identified as PGR-regulated
and potentially involved in follicular rupture. Interestingly, none of these PGR-regulated genes has been
demonstrated to be a direct transcriptional target of PGR. Rather, in ovarian granulosa cells, PGR may act as
an inducible coregulator for constitutively bound Sp1/Sp3 transcription factors, which are key regulators for
a discrete cohort of ovulatory genes.
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Introduction
The two main functions of the ovary are production of
reproductive hormones that synchronize the reproductive
cycle and to nurture and release oocytes capable of
fertilization and development into live offspring. Both
processes occur within ovarian follicles, and progress
through highly orchestrated developmental stages to
culminate in the simultaneous release of a
developmentally-competent oocyte and elevated
production of progesterone that primes uterine receptivity.
Progesterone is traditionally known to be essential for
pregnancy maintenance (hence ‘pro-gestation’), but the
hormone also plays a critical physiological role in the
ovary. Its effects are mediated by progesterone receptors
(PGRs), which are members of the nuclear receptor
superfamily of transcription factors (NR3C3) [Evans, 1988;
Schrader and O'Malley, 1972;Tsai and O'Malley, 1994].
The progesterone receptor (PGR) has been identified as
an important regulator of gene transcription during the
peri-ovulatory period, specifically of genes found to be
necessary for successful oocyte release from the
preovulatory follicle.
Hormonally-regulated expression of
progesterone receptor in the ovary
Physiological events in the ovulating follicle
Ovarian follicle development is controlled by pituitary FSH
and LH (or treatment with PMSG), which maintain follicle
growth up to the preovulatory stage. In these follicles, the
somatic cells which surround the fluid-filled antral cavity
have differentiated into cumulus cells that encase the
oocyte, mural granulosa cells which line the follicle wall
and theca cells which lie outside the follicular basement
membrane on which the mural granulosa cells sit. FSH
stimulates the production of high levels of estrogens and
the appearance of LH receptors, predominantly on mural
granulosa cells [Eppig et al., 1997; Peng et al., 1991].
The mural cells then respond to the ovulatory LH surge
(or treatment with hCG) by ceasing proliferation and
undergoing luteinization, a terminal differentiation whereby
they become highly steroidogenic, synthesizing elevated
progesterone that acts on the uterus to prepare it for
implantation and subsequent pregnancy maintenance.
The cumulus cells undergo cumulus expansion as a
secondary response to EGF-like ligands released by
granulosa cells responding to LH [Park et al., 2004].The
unique extracellular matrix that forms envelops the
cumulus oocyte complex and is important for successful
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and Robker, 2007]). At the same time, the oocyte
resumes meiosis and undergoes maturation to become
competent for ovulation and fertilization.
LH-induction of progesterone receptor (PGR)
expression
Activation of the G-protein coupled LH-receptor (LH-R)
on mural granulosa cells in response to the LH surge
stimulates adenylate cyclase (AC), increases intracellular
cAMP, thereby activating protein kinase A (PKA) and
inducing expression of PGR ( Figure 1).This induction
can be prevented by blockade of the LH surge with
pentobarbital [Park and Mayo, 1991] or mimicked by using
cell permeable cAMP or by activating adenylate cyclase
with high doses of FSH or forskolin [Park-Sarge and
Mayo, 1994].The LH surge via PKA also activates MAPK
[Russell et al., 2003; Salvador et al., 2002], which is
essential for the induction of PGR, since mice lacking
ERK1/2 in granulosa cells fail to express PGR mRNA in
response to ovulatory hCG [Fan et al., 2009]. Surge levels
of LH also activate protein kinase C (PKC) and inclusion
of the PKC activator PMA with forskolin in cultured
granulosa cells causes a synergistic induction of PGR
[Sriraman et al., 2003].
Figure 1. The LH surge transcriptionally regulates PGR expression
in rodent granulosa cells. LH binding to its receptor activates adenylate
cyclise (AC), stimulating the production of cAMP and activation of protein
kinase A (PKA).The LH surge also activates protein kinase C (PKC),
which acts synergistically with PKA to induce PGR mRNA expression.
PKA activates MAP kinase (MAPK) and its downstream kinases (ERK1/2)
in granulosa cells.The downstream targets of these kinases required for
PGR induction are currently unknown.The distal region of the PGR
promoter contains a CAAT box which binds NF-YB transcription factor,
a GC-rich region which binds Sp1/3, and a GATA site which binds GATA4.
The proximal promoter consists of an ERE1/2 site, two Sp1/Sp3binding
sites and a series of ERE sites. Interestingly, the only essential regulatory
sites are the Sp1/Sp3 sites, and even though estrogen receptors are
abundant in granulosa cells, they do not bind the EREs. How the
constitutively bound Sp1/Sp3 controls transcription at the PGR promoter
is not known, but is thought to involve the recruitment of additional, yet
to be identified, coregulatory factors. (Sequence numbering based on the
murine PGR promoter and adapted from Sriraman et al., 2003).
PGR expression in response to LH or forskolin only
occurs in granulosa cells of preovulatory follicles
[Park-Sarge and Mayo, 1994] or those that have been
differentiated in FSH plus testosterone or estradiol
[Clemens et al., 1998].The presence of estrogen receptor
antagonist ICI182780 during granulosa cell differentiation
blunts the induction of PGR by cAMP [Clemens et al.,
1998] and ERβ-/- mice exhibit reduced PGR expression
due to lower LH-R expression and impaired cAMP
production [Deroo et al., 2009].
Within the PGR gene, mRNA expression is regulated by
alternate promoters [Kastner et al., 1990; Kraus et al.,
1993] and a series of studies on the rodent PGR promoter
have identified the key regulatory regions in granulosa
cells ( Figure 1) [Clemens et al., 1998; Park-Sarge and
Mayo, 1994; Park-Sarge et al., 1995; Sriraman et al.,
2003]. In contrast to other cell types in which PGR
induction has been well characterized, the ERE-like
elements do not bind ER in granulosa cells, but interact
synergistically with the GC-rich distal promoter [Clemens
et al., 1998], with both regions retaining constitutively
bound Sp1/Sp3 proteins, which are required for maximal
induction of PGR mRNA expression in response to the
LH surge [Clemens et al., 1998; Sriraman et al., 2003].
The molecular mechanism by which Sp1/Sp3 controls
transactivation of the PGR gene is not known, but is
thought to involve recruitment of additional, as yet
unidentified, transcriptional regulators to the PGR
promoter. Further, how the kinases which are essential
for PGR induction modify the transcriptional complex is
not known.
PGR mRNA give rise to two protein isoforms, PGR-A
(72-94 kDa) and PGR-B (108-120 kDa) [Saqui-Salces et
al., 2008; Schrader and O'Malley, 1972] controlled by two
distinct translation initiation sites [Conneely et al., 1989;
Conneely et al., 1987; Graham and Clarke, 2002; Kastner
et al., 1990]. PGR-A and PGR-B are identical except for
PGR-A, the shorter form, missing the first 165 amino
acids at the amino-terminus that contains one of the three
activation function domains possessed by PGR-B
[Giangrande and McDonnell, 1999; Graham and Clarke,
2002].
PGR expression in the rodent ovary
PGR mRNA and protein isoforms are expressed in a
temporally and cell-type restricted manner in the ovary.
PGR mRNA is rapidly yet transiently induced in the rat
ovary in vivo [Park and Mayo, 1991] and in primary
cultures of rat granulosa cells, peaking after 4-8h in
response to LH [Clemens et al., 1998; Natraj and
Richards, 1993]. PGR mRNA expression has not been
directly localized in the mouse, but the PRlacZ mouse
model, whereby the lacZ reporter was placed within exon
1 of the PGR gene, demonstrates that PGR is expressed
within 4h of the LH surge, specifically in mural granulosa
cells (Figure 2) [Ismail et al., 2002]. PGR protein has also
been localized to granulosa cells of mouse preovulatory
follicles, transiently up-regulated at 4h and 8h post-hCG
[Robker et al., 2000] and undetectable by 12h. Consistent
with differences in LH-R expression, PGR is expressed
at dramatically higher levels in mural granulosa cells than
in cumulus cells (Figure 2) [Ismail et al., 2002; Robker et
al., 2000;Teilmann et al., 2006].
PGR-A and PGR-B specific antibodies were used to show
distinct expression of the two protein isoforms in the
mouse ovary [Gava et al., 2004]. In contrast to other
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detected throughout the ovary. PGR-A was most highly
expressed in granulosa cells of preovulatory follicles and
the corpus luteum on the morning of estrus, as well as in
the theca of preantral and antral follicles consistent with
other observations, including our own of PGR protein in
isolated cells within the ovarian theca and stroma in
response to the LH surge (Robker, unpublished data). In
granulosa cells, however, PGR-A is clearly the more
prevalent translated product in the rat [Natraj and
Richards, 1993] and mouse [Shao et al., 2003;Teilmann
et al., 2006] following the LH surge.
Figure 2.  Progesterone receptor (PGR) is expressed in the ovary
in a temporal and cell-type specific manner, as demonstrated by
PRlacZ mice, which express the lacZ reporter (blue) under the control
of the endogenous PGR promoter. Top panels: Ovaries from mice
treated with PMSG do not express PGR, while the oviduct expresses high
levels. Middle panels: In response to hCG to mimic the LH surge, lacZ
staining is detected within 8h, specifically in the granulosa cells of
preovulatory follicles. Lower panel: In preovulatory follicles, lacZ is
detected in mural granulosa cells (blue arrow), but not cumulus cells
(black arrow) or the oocyte (O). (Reprinted with permission from Ismail
et al., 2002). Copyright 2002, The Endocrine Society.
PGR expression in primate and human ovary
Unlike the very transient pattern of PGR expression
observed in rodents, primates and humans display more
prolonged expression of PGR in the ovary, which is
thought to function in the extended luteal phase in these
species. Immunohistochemistry of ovaries from rhesus
or cynomologus monkeys throughout the menstrual cycle
showed PGR protein in granulosa of some primordial and
primary follicles, but not granulosa of follicles beyond the
primary stage [Hild-Petito et al., 1988]. Highest levels of
expression were observed in luteinizing granulosa in
follicles that had responded to the LH surge and in theca
of follicles at all stages. CL from the early and mid-luteal
phases expressed PGR protein, but late-luteal and
regressing CL did not [Hild-Petito et al., 1988].
Figure 3.  Mice null for PGR (PRKO) demonstrate that PGR is
essential for ovulation, particularly follicular rupture, but not follicle
growth or luteinization. Upper panels show ovary sections from mice
heterozygous or null for PGR that were treated with PMSG to stimulate
preovulatory follicle growth. Lower panels show ovary sections from mice
treated with PMSG followed by hCG for 48h to stimulate ovulation and
luteinization. Lower right panel shows that in PRKO mice, oocytes remain
trapped within luteinized follicles. (Reprinted with permission from Robker
et al., 2000).
There are very few reports of PGR protein localization in
the human ovary. Consistent with all other species
examined, PGR is expressed in the dominant follicle at
the time of the LH surge [Iwai et al., 1990] and similar to
other primates, PGR expression is maintained in the
active CL, but not in the late CL [Iwai et al., 1990; Revelli
et al., 1996; Suzuki et al., 1994]. PGR is also consistently
observed in the theca of some follicles and the stroma
[Iwai et al., 1990; Revelli et al., 1996; Suzuki et al., 1994]
and interestingly, was detected in a small proportion of
primordial follicles and preantral follicles [Revelli et al.,
1996]. More work is clearly needed, however, to clarify
the expression patterns of PGR mRNA and protein
isoforms in the human ovary.
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receptor in the ovary
Receptor antagonists and genetically modified mouse
models have been used to delineate the role of PGR in
ovarian function. PGR is likely to have multiple roles in
the ovary, including modulation of granulosa-lutein cell
survival and steroidogenesis, cumulus expansion and
oocyte quality, depending on the species. However,
studies in many species, including humans, consistently
demonstrate that PGR signaling is essential for release
of the oocyte at ovulation.
Ovulation
RU486, or mifepristone, is a mixed PGR
agonist/antagonist [Chabbert-Buffet et al., 2005], which
has been used extensively to experimentally demonstrate
the function of PGR both in vitro and in vivo.
Administration of RU486 to cycling female mice [Loutradis
et al., 1991] or rats [Gaytan et al., 2003; Sanchez-Criado
et al., 1990; van der Schoot et al., 1987] prevented or
reduced follicle rupture. Similar results occur with more
specific unambiguous anti-progestagens: ZK28299
(Onapristone) inhibited ovulation in rats [Uilenbroek, 1991]
and Org31710 inhibited ovulation in an in vitro-perfused
rat ovary model [Pall et al., 2000]. CDB-2914, which
exhibits improved specificity and efficacy as an
anti-progestin compared to RU486, due to reduced
anti-glucocorticoid activity [Attardi et al., 2004; Attardi et
al., 2002; Hild et al., 2000], blocked ovulation in rats [Reel
et al., 1998] and severely impaired ovulation in mice
[Palanisamy et al., 2006].These PGR antagonist
treatments were effective when delivered 5h [Gaytan et
al., 2003] or 1h [Palanisamy et al., 2006] prior to LH
administration, concurrent with the LH surge [Loutradis
et al., 1991; Pall et al., 2000] or 3.5h post-LH
administration [Pall et al., 2000], but not at 7 or 9h post-LH
[Pall et al., 2000].This indicates that PGR is important
early in the ovulatory process and becomes superfluous
once its cascade of activity has been set in motion.
PGR antagonists also exhibit anti-ovulatory activity in
women. Follicular phase administration of RU486 [Liu et
al., 1987; Shoupe et al., 1987; Spitz et al., 1993] or
CDB-2914 [Stratton et al., 2000] blocks or delays
ovulation in a dose-dependent manner. Moreover, women
who received CDB-2914 in the mid-follicular phase
exhibited a significant incidence of luteinized unruptured
follicles [Stratton et al., 2000].
Cumulatively, these studies using PGR antagonists
support a large body of work which had previously
demonstrated that the progesterone ligand itself is
essential for ovulation [Espey et al., 1989; Hibbert et al.,
1996; Kohda et al., 1980; Lipner and Greep, 1971; Mori
et al., 1977; Snyder et al., 1984].
Targeted deletion of the PGR gene in mice, the PRKO
(progesterone receptor knockout) model, has allowed
definition of the specific and direct role of PGR in female
fertility [Lydon et al., 1995]. PRKO homozygous females
develop normally to adulthood, but the ovaries, uterus,
mammary gland and brain exhibit altered phenotypes,
demonstrating that PGR exerts pleiotropic control over
reproductive tissues [Lydon et al., 1996; Lydon et al.,
1995].Within the ovary of PRKO mice there is normal
growth and development of ovarian follicles until the
preovulatory stage. However, the mice exhibit profound
and complete anovulation, even in response to
hyperstimulation with gonadotropins, resulting in oocytes
retained in unruptured follicles (Figure 3) [Lydon et al.,
1995; Robker and Richards, 2000]. Despite impaired
follicular rupture, granulosa cells from preovulatory
follicles of PRKO mice respond to the LH surge, as
demonstrated by the presence of cumulus expansion
[Lydon et al., 1995]; normal LH-induced upregulation of
COX-2 (cyclooxygenase-2), an enzyme that catalyzes
prostaglandin production and is essential for ovulation
[Robker et al., 2000]; and differentiation into a luteal
phenotype assessed by normal expression of the luteal
marker P450 side-chain cleavage enzyme [Robker et al.,
2000].Therefore, PGR is not required for follicle growth
and development or granulosa cell differentiation or
luteinization, but is specifically and absolutely required
for rupture of the preovulatory follicle and oocyte release.
More recently, mouse models were generated which lack
either the PGR-A or PGR-B isoform in order to determine
the relative contributions of each to the myriad
reproductive phenotypes observed in the PRKO mice.
The isoform-specific knockouts were produced using
CRE-loxP gene targeting to introduce mutations at either
the ATG codon encoding Methionine 1 (M1A) to ablate
expression of the PGR-B protein (PRBKO) or Methionine
166 (M166A) to ablate expression of the PGR-A protein
(PRAKO) [Mulac-Jericevic et al., 2003; Mulac-Jericevic
et al., 2000]. Histology of PRAKO mouse ovaries is similar
to PRKO mice, with numerous mature anovulatory follicles
containing an intact oocyte [Mulac-Jericevic et al., 2000].
Stimulation of immature PRAKO mice with exogenous
gonadotropins further demonstrated a severe impairment
in ovulation compared to WT mice, but not as complete
as in PRKO mice, where both isoforms were ablated
[Conneely et al., 2002; Mulac-Jericevic et al., 2000].
Superovulation was unaffected in PRBKO mice which
only express the PGR-A protein [Mulac-Jericevic et al.,
2003].Thus, PRKO mouse models clearly demonstrate
the critical importance of the PGR-A isoform in ovulation.
Furthermore, the fact that PGR-A alone is capable of
supporting ovulation indicates that synergy between
PGR-A and PGR-B proteins are not required for regulation
of essential P-responsive genes associated with ovulation.
An area ripe for investigation is the utilization of
microarray techniques to examine differentially expressed
genes in PRAKO and PRBKO mice, which will allow
PGR-A–selective target genes essential for ovulation to
be identified. A recent report has verified that, indeed,
when PGR-A or PGR-B is delivered to mouse granulosa
cells in vitro, unique genes are induced by each [Sriraman
et al., 2009].
Oocyte developmental competence
Even though ovulation is completely blocked in PRKO
mice, oocyte developmental competence does not seem
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preovulatory follicles of PMSG-primed PRKO mice can
be successfully matured and fertilized in vitro  and exhibit
normal blastocyst development rates and produce pups
following uterine transfer [Robker and Richards, 2000].
However, another study showed that treatment of mice
with the PGR antagonist RU486 24h after PMSG resulted
in a 50% decrease in the number of two-cell embryos
that progressed to the blastocyst stage [Loutradis et al.,
1991].
In porcine COCs treated with FSH and LH to induce
expression of PGR, RU486 blocked oocyte progression
to MII and development to blastocyst [Shimada et al.,
2004b]. In this model, PGR is abundantly expressed by
cumulus cells and treatment with RU486 also significantly
impairs cumulus expansion [Shimada et al., 2004a;
Shimada et al., 2004b]. PGR is not normally expressed
in cumulus cells of the mouse and in PRKO ovaries
cumulus expansion is not overtly affected [Lydon et al.,
1995; Robker et al., 2000].
The role of progesterone and specifically PGR in the
regulation of cumulus expansion in humans has not been
adequately examined. In a single report, analysis of 135
cumulus cell samples collected from 44 IVF patients at
the time of oocyte aspiration found that there was no
relationship between PGR expression and oocyte
fertilization or cleavage rate [Hasegawa et al., 2005].
However, low expression levels of PGR mRNA,
regardless of follicular fluid P levels, was correlated with
subsequent good embryo quality (defined as embryos
with ≥7 blastomeres and <5% fragmentation at d3
post-fertilization) [Hasegawa et al., 2005]. Cumulatively,
these studies indicate that a better understanding of the
subtle effects of PGR in the peri-conception COC is
needed.
Granulosa cell survival and steroidogenesis
PGR has a role in preventing granulosa cell apoptosis
during luteinization. Mice treated with RU486 prior to
ovulatory hCG have increased caspase-3 activity, a
measure of increased apoptosis, in granulosa cells of
preovulatory follicles [Shao et al., 2003]. Further, culture
of periovulatory mouse [Shao et al., 2003], rat or human
[Rung et al., 2005] granulosa cells with RU486 or
Org31710 increases DNA laddering, indicative of cellular
apoptosis. Caspase-3 activity [Svensson et al., 2001] and
TUNEL positivity [Makrigiannakis et al., 2000] have also
been reported in human luteinizing granulosa cells in
response to either RU486 or Org31710.
Cholesterol synthesis by rat and human periovulatory
granulosa cells in vitro is inhibited by RU486 or Org31710
[Rung et al., 2005; Shao et al., 2003; Svensson et al.,
2000], suggesting a role for PGR in steroid synthesis
during luteinization. In PRKO mice, basal progesterone
levels are not different to normal littermates [Chappell et
al., 1997], however steroidogenesis and luteal function
has not been closely examined in any of the PGR null
mouse models. In non-human primates and humans,
species with long luteal cycles, it is clear that PGR
regulates steroidogenesis in the early corpus luteum
(reviewed in [Park and Mayo, 1991; Stouffer, 2003;
Stouffer et al., 2007]). Furthermore, based on expression
patterns, it is likely that PGR-B in particular regulates
luteinization, while PGR-A controls ovulation [Stouffer et
al., 2007]. Although PGR has a role in periovulatory
granulosa cell survival and steroidogenesis, in primates
at least, there is no evidence at present to suggest that
these functions contribute to its critical role in follicular
rupture.
Peri-ovulatory genes regulated by PGR
The profound anovulation of female PRKO mice has led
to intense interest in the identification of PGR-regulated
genes. In the ovary this has been pursued primarily via
cDNA array hybridization analysis of transcripts from
ovarian cells and cultured follicles of PRKO mice
compared to heterozygotes, or isolated rodent granulosa
cells cultured in the presence or absence of
anti-progestins such as CDB-2914 or RU486 ( Table 1).
The currently identified genes that appear to be regulated
by PGR are proteases, growth factors, signal transduction
components and transcription factors. For the majority of
these genes, their specific function in ovulation remains
to be elucidated, and roles in luteinization and/or luteal
cell survival cannot be discounted.
Proteases regulated by PGR
Ovulation requires the action of proteases to facilitate
release of the oocyte from within the follicular structure
[Butler and Woessner, 1994; Butler et al., 1991] and lack
of proteolytic tissue remodeling has been hypothesized
to contribute to the anovulatory phenotype of the PRKO
mouse [Robker et al., 2000]. At least three proteases
(ADAMTS1, cathepsin L and ADAM8) appear to be
directly or indirectly regulated by PGR (see Table 1), as
they are selectively induced in large ovulatory follicles
and absent in follicles from PRKO mice [Robker et al.,
2000; Sriraman et al., 2008]. However, to date, ADAMTS1
is the sole protease with a clearly identified role in ovarian
function.
The extracellular matrix protease Adamts1 (a disintegrin
and metalloproteinase with thrombospondin motif 1) is
induced in mural granulosa cells of the mouse ovary in
response to ovulatory hCG, an induction that fails to occur
in PRKO mice [Robker et al., 2000]. ADAMTS1 protein,
the pro-form and the proteolytically-active form, is also
deficient in PRKO mice, resulting in reduced cleavage of
the matrix protein versican within the COC [Russell et al.,
2003].These results suggest that PGR-mediated
induction of Adamts1 regulates ovulatory events, a finding
substantiated by the subfertile phenotype of Adamts1 null
mice, which release, on average, only 12 oocytes
compared to 41 from heterozygote littermates after
controlled gonadotropin stimulation [Mittaz et al., 2004].
In addition, Adamts1 null mice exhibit altered cumulus
matrix structure, which impacts fertilization in vivo (D.
Russell, unpublished data). Ovarian histology of Adamts1
null mice is also reminiscent of that of PRKOS, including
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order that they appear in the text.The evidence for PGR regulation includes reduced (↓) or increased (↑) expression in PRKO mouse models or inhibition
(square encasing x) in response to PGR antagonists. Gene products that have been demonstrated to be critical for ovulation are indicated (star). gc =
granulosa cells.
luteinized follicles which express P450scc normally, but
contain entrapped oocytes [Mittaz et al., 2004].
Growth factors and signal transduction
components
A large number of cellular signaling genes have been
identified as being PGR-regulated (see Table 1). For the
majority, their roles in ovulation are unclear, although the
potent vasoactive endothelins (Edn) appear to play an
important role. Endothelin 2 (Edn2) is expressed
specifically in mural granulosa cells, peaking at 12h
post-hCG and then rapidly (within 1h) down-regulated
[Palanisamy et al., 2006]. Edn2 is undetectable in ovaries
from gonadotropin-stimulated PRKO mice and expression
cannot be induced in PRKO primary granulosa cell
cultures by treatment with an ovulatory stimulus such as
forskolin (Fo) or phorbol myristate acetate (PMA)
[Palanisamy et al., 2006]. Endothelin-1 (Edn1) was more
recently identified as a PGR-A induced gene in mouse
granulosa cells that is not expressed in ovaries from
PRKO mice [Sriraman et al., 2009] . Endothelins are likely
to be important players in the ovulatory cascade, as
treatment with endothelin receptor antagonists severely
decrease ovulation rate and result in ovaries with
unruptured preovulatory follicles [Ko et al., 2006;
Palanisamy et al., 2006].
Other PGR-regulated genes have known roles in the
ovary.The EGF-like ligands amphiregulin (Areg) and
epiregulin (Ereg) play key roles in triggering cumulus
expansion and meiotic resumption in response to
ovulatory LH [Ashkenazi et al., 2005; Park et al., 2004].
While Areg null mice have a normal ovulation rate, that
of Ereg null mice is greatly reduced [Hsieh et al., 2007].
Inhibition of EGF receptor activation by injecting AG1478
into the ovarian bursa of the rat can modestly, but
significantly, reduce ovulation rate in a dose dependent
manner [Ashkenazi et al., 2005]. Similarly, a hypomorphic
mutation in the EGF-R in mice results in dramatically
reduced ovulation [Hsieh et al., 2007].
The cytokine IL-6 is reduced in PRKO mice [Kim et al.,
2008], as is synaptosomal-associated protein-25 (SNAP
25), a component of the SNARE exocytosis complex that
promotes cytokine secretion by both the COC and
granulosa cells [Shimada et al., 2007].Thus, via
regulation of both cytokine production and secretion, PGR
may play a role in the inflammatory reaction that is
associated with the process of ovulation.
In the case of other putative PGR-regulated signaling
molecules, such as cGKII [Kim et al., 2008; Sriraman et
al., 2006], SUMO-1 [Shao et al., 2004] and ApoA1
[Sriraman et al., 2009], their roles in ovulation are not
clear, or they may be involved in the terminal
differentiation of granulosa cells rather than follicular
rupture. For instance, pituitary adenylate cyclase
activating polypeptide (PACAP) is induced in granulosa
cells of preovulatory follicles via LH- and PGR-mediated
mechanisms [Ko et al., 1999; Ko and Park-Sarge, 2000;
Park et al., 2000]. PACAP null female mice have normal
rates of ovulation and fertilization, yet only a small
percentage of females have successful implantation, a
defect thought to be due to their reduced prolactin and
progesterone levels [Isaac and Sherwood, 2008].Thus,
PGR-mediated induction of the PACAP pathway appears
to be more important for the establishment of luteinization
rather than ovulation.
Transcription factors
Cited1 is a transcription factor which is induced by PGR-A
in granulosa cells in vitro and exhibits reduced expression
in vivo in PRKO ovaries [Sriraman et al., 2009]. Cited1
expression and function have yet to be characterized in
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Cited1 null mouse model [Howlin et al., 2006].
Following identification of PPARγ (peroxisome
proliferator-activated receptor γ) as a molecular target of
PGR [Kim et al., 2008], its role in ovulation was tested
using transgenic PR-Cre knock-in mice crossed with
PPARγ-floxed mice to delete PPARγ specifically in cells
which express PGR.Thus, PPARγ deletion occurred
specifically in mural granulosa cells, but not cumulus cells
of preovulatory follicles. Follicular development was
unaffected. However, the conditional PPARγ-null females
(PPARγ
flox/flox PR
cre/+) had severely reduced ovulation rates,
with histological analysis of the ovaries showing an
absence of CL and abundant unruptured follicles [Kim et
al., 2008]. Importantly, PPARγ appears to be responsible
for the induction of other genes previously acknowledged
as PGR-regulated genes, since Edn2, cGKII and IL-6
mRNA, each of which are disrupted in PRKO ovaries,
were also decreased in PPARγ
flox/flox PR
cre/+ ovaries [Kim
et al., 2008]. However, expression of the PGR-regulated
gene Adamts1 was not altered in PPARγ
flox/flox PR
cre/+
ovaries [Kim et al., 2008], indicating PPARγ only regulates
a subset of PGR-regulated genes.
Figure 4.  A working model of PGR-dependent pathways that are
essential for ovulatory events. The LH surge induces the expression
of PGR specifically in granulosa cells, as well as luteinization-specific
genes including steroidogenic enzymes that synthesize progesterone
(StAR, P450scc), as well as PGR. Locally secreted progesterone (P4)
activates PGR, which then transactivates intermediary genes including
Hif1α (which is presumably also dependent on hypoxic conditions), which
acts in concert with PGR to induce Adamts1 and VegfA. PGR regulation
of EGF-like ligands Areg and Ereg would stimulate EGF-R, including that
present on cumulus cells. PGR-mediated PPARγ induction acts upon
ligand activation, perhaps supplied by COX-2 generated products such
as PGJ2, to transactivate genes including Edn2. Edn2 receptors Ednrb
are present on cumulus cells, as well as on ovarian smooth muscle cells.
Oocyte-secreted factors (OSFs) regulate the induction of COX-2 and
prostaglandin PGE, which acts on EP2 receptors, specifically in cumulus
cells.Through this sequential cascade of PGR-initiated gene induction,
integrated functional events including protease activation, cumulus
expansion, smooth muscle contraction, vascular permeability and
angiogenesis all contribute to follicle rupture and oocyte release.
Activating ligands of PPARγ include fatty acid metabolites,
such as prostaglandin J2 produced by COX-2 enzyme.
Indomethacin and the more specific COX-2 inhibitor
NS-398 blocked the induction of the PPARγ-regulated
genes (EDN2, cGKII and IL-6) in cultured mouse
granulosa cells stimulated with Fo/PMA [Kim et al., 2008].
Thus, it appears that through the induction of PPARγ by
LH-PGR regulation and its ligands by COX-2, endocrine
and oocyte-controlled signaling pathways converge to
promote ovulatory induction of EDN2, cGKII and IL-6
(Figure 4).
More recently, Hypoxia-Inducible Factor (HIF)
transcription factors Hif1α, Epas1 ( formerly known as
Hif2α) and Hif1β have been identified as transcriptionally
regulated PGR-dependent genes [Kim et al., 2009]. Hif
activity is likely to be important for follicular rupture, since
treatment of mice with echinomycin, which blocks Hif
DNA binding, blocked follicle rupture [Kim et al., 2009].
Echinomycin treatment in vivo also blocked the
hCG-stimulated induction of PGR-target genes Adamts1
and endothelin-2, but not Hif1α or Adam8 [Kim et al.,
2009], suggesting that HIF transcription factors are also
essential mediators of expression for a subset of
PGR-regulated genes (Figure 4).
Thus, genes that are PGR-regulated in vivo have been
identified primarily via their altered expression in PRKO
mice or in response to treatment with PGR antagonists,
with the majority yet to be confirmed in replicated studies.
Further, whether any of these genes are in fact direct
targets of PGR in ovarian cells has not been determined.
Studies to date attempting to answer this question have
found that in ovarian cells, PGR-regulation of gene
expression is complex and currently not well-understood.
PGR regulation of transcription in
granulosa cells
Agonistic progestin ligand binding to PGR causes a
conformational change and receptor dimerization to
facilitate binding to PGR response elements (PRE) in
gene promoters [O'Malley, 2005; Spitz, 2006].The two
PGR isoforms, PGR-A and PGR-B, have different
transcriptional activities [Giangrande et al., 2000], due to
the presence of an additional activation function domain,
AF3, on the longer PGR-B isoform [Saqui-Salces et al.,
2008; Schrader and O'Malley, 1972]. Aside from this,
both isoforms comprise identical ligand binding and
DNA-binding domains [Gellersen et al., 2009; Hager et
al., 2000; Mulac-Jericevic and Conneely, 2004].The
PGR-A isoform, which has the predominant role in
ovulation, can act as both a repressor and activator of
transcription, depending on the cell type [Graham and
Clarke, 2002;Vegeto et al., 1993]. Interestingly, a
mutation in the hinge region of human PGR, which is
essential for its regulatory functions, is associated with
unexplained infertility in women [Pisarska et al., 2003].
Ligand-activated PGR interacts with and recruits steroid
receptor coactivators that modify chromatin structure to
facilitate assembly of a macromolecular transcription
complex. Further, PGR can be activated in the absence
of steroidal ligand by phosphorylation pathways that
modulate interactions with coregulator proteins [Rowan
et al., 2000; Rowan and O'Malley, 2000]. Interestingly,
PGR-A appears to exhibit greater ligand-independent
transcriptional activity than PGR-B in mouse granulosa
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PGR isoform expression, is the suite of coactivators and
repressors present in any cellular context.While these
have not been exhaustively studied in granulosa cells,
the coactivator p120 is induced by gonadotropins in rat
granulosa cells and potentiates responsiveness to
steroids including progesterone [Yoshino et al., 2006],
indicating that this classical nuclear hormone signaling
is a key response to the LH surge.
Figure 5.  Regulatory elements in the ADAMTS1 promoter, a
well-characterized PGR-responsive gene in granulosa cells. The
LH surge induces a suite of transcription factors including C/EBPβ, Egr-1
and PGR. C/EBPβ and Egr-1 have been demonstrated to directly bind to
the Adamts1 promoter at sites that are essential for induction in response
to ovulatory cAMP (Doyle et al., 2004). In contrast, there are no PREs in
the promoter and PGR-dependent transcription is proposed to occur via
PGR acting as an inducible coregulator with Sp1/Sp3 transcription factors,
which are constitutively bound to a series of GC-rich regions (I, II, and
III). BTM = basal transcriptional machinery.
Intriguingly, even though PGR can transduce reporter
constructs bearing canonical PRE-dependent promoters
in granulosa cells [Doyle et al., 2004], genes identified
as PGR-regulated in granulosa cells lack PGR binding
response elements in their upstream promoters.Thus,
in granulosa cells, unique transcriptional mechanisms
are mediated by PGR to regulate a discrete set of
peri-ovulatory genes. Of the PGR-regulated genes that
have been analyzed to date, their expression in granulosa
cells is dependent on GC-box promoter elements that
bind specificity protein (Sp1 or Sp3) and early growth
response protein-1 (Egr1) transcription factors.
Interestingly, these are similar to elements that regulate
the induction of PGR itself, but are presumably
PGR-independent. Close analysis of the gene promoter
of Adamts1, the best characterized granulosa cell
PGR-regulated gene (Figure 5), revealed that
PGR-mediated induction in mouse granulosa cells
requires proximal GC-box elements that bind Sp1/3 [Doyle
et al., 2004].Transactivation of the Adam8 and cGKII
genes by LH or its analogues was also found to be
disrupted in PRKO mice and could be augmented in vitro
by exogenous PGR-A overexpression [Doyle et al., 2004;
Sriraman et al., 2008; Sriraman et al., 2006]. As with
Adamts1, this activity was dependent on GC-box
elements in the proximal promoter and also appears to
involve a nuclear factor-1-like element [Sriraman et al.,
2008]. Analysis of the rat cathepsin L promoter
demonstrated Sp1/3 dependent induction after the LH
surge, but the lack of any in vitro experimental
progesterone responsiveness in this system prevented
determination of a role for PGR [Sriraman and Richards,
2004]. For the cellular signaling factor SNAP25, in vitro
induction mediated directly by PGR-A overexpression
was also dependent on the GC-box Sp1/3 binding region
of the promoter [Shimada et al., 2007]. However, for
cGKII, Areg and Ereg the mechanism of PGR-dependent
regulation has not been studied. Further, there is evidence
to suggest that PGR may only control maintenance of
expression or message stability in these genes, rather
than the initial induction of expression [Shimada et al.,
2006; Sriraman et al., 2006].
Transcription factors induced downstream of PGR, such
as Cited1, PPARγ and HIFs, may also influence
expression of what are considered PGR-regulated genes,
yet whether these act via direct DNA binding or indirect
mechanisms to regulate ovulatory events is not yet
known. PPARγ induced by PGR was shown to regulate
endothelin-2, cGKII and IL-6 [Kim et al., 2008], while HIF
activity was shown to regulate Adamts1 and endothelin-2
[Kim et al., 2009]. It is important to note that blockade of
HIF activity with echinomycin also disrupts Sp1/Sp3
transcriptional activity [Vlaminck et al., 2007], so it is
unclear whether genes identified by this method are truly
HIF-regulated or Sp1-regulated.
Thus, in contrast to all that is known about PGR-regulation
of transcription in other reproductive tissues, it is not
known how PGR regulates the transcription of its
peri-ovulatory gene cohort in granulosa cells. Current
evidence based on bioinformatic analysis of
PGR-dependent genes and an in depth study of the
Adamts1 gene promoter suggest that PGR transcriptional
regulation in granulosa cells does not depend on direct
DNA binding to proximal promoter elements. Indirect
interaction of PGR with gene promoters through binding
to Sp1 proteins is a common mechanism of
PGR-dependent gene induction, which has mainly been
investigated in breast cancer cell lines where direct
interaction of Sp1 and PGR has been confirmed [Faivre
et al., 2008; Gizard et al., 2006].Thus, while experiments
definitively confirming that PGR interacts with Sp1/3 in
granulosa cells are lacking, the evidence for this in other
cell types and the consistent dependence on Sp1/3
binding promoter elements for peri-ovulatory
PGR-mediated gene induction in granulosa cells suggests
that this is the main mechanism for transcription.
Conclusions
PGR is a key specific regulator of ovulation across
species. It is induced by the LH surge specifically in
granulosa cells of mature preovulatory follicles. A number
of granulosa cell PGR-regulated genes have been
identified via their mis-expression in PRKO mice or in
response to anti-progestins, and a subset appear to be
involved in follicular rupture. However, whether these are
direct transcriptional targets of PGR or indirectly
downstream has yet to be clarified. Interestingly, the
genes that have been analyzed lack PREs in the promoter
regions, but rather require constitutively bound Sp1/Sp3
transcription factors.Thus, in granulosa cells, PGR may
be acting as a “coregulator” of Sp1/Sp3 activity to
coordinately induce a discrete cohort of essential
ovulatory genes.
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